Zura Bio Limited
ZURA | NASDAQ
$4.55
+$0.05 (+1.11%)
Sep 22, 2026, 11:24 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 |
|---|---|---|---|---|---|
Net Income | -68.65M | -52.4M | -60.56M | -27.33M | 8.42M |
Depreciation & Amortization | 49K | 9K | n/a | n/a | n/a |
Stock-Based Compensation | 12.33M | 16.8M | 9.66M | 334K | n/a |
Other Working Capital | -1.47M | -1.91M | 5.12M | 3.25M | -238.47K |
Other Non-Cash Items | -4.91M | 5.21M | 30.74M | 22.26M | -9.28M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -3.63M | 2.31M | 5.12M | 3.54M | -235.6K |
Operating Cash Flow | -64.82M | -28.08M | -15.05M | -1.2M | -1.1M |
Capital Expenditures | -113K | -75K | -8M | -12M | -4 |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | -139.38M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | -5M | n/a | n/a | n/a |
Investing Cash Flow | -113K | -5.08M | -8M | -12M | -139.38M |
Debt Repayment | n/a | n/a | -10M | 7.6M | -117.38K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -7.37M | 49.09M | 14.89M | -2.83M | 505K |
Financial Cash Flow | -2.16M | 109.84M | 121.29M | 14.77M | 141.21M |
Net Cash Flow | -67.09M | 76.69M | 98.24M | 1.57M | 729.22K |
Free Cash Flow | -64.93M | -28.15M | -23.05M | -13.2M | -1.1M |
Adj. Free Cash Flow | -77.26M | -44.95M | -32.71M | -13.54M | -1.1M |
Maintenance CapEx | -49K | -9K | n/a | n/a | n/a |
Growth CapEx | -64K | -66K | -8M | -12M | -4 |
Owner Earnings | -64.86M | -28.09M | -15.05M | -1.2M | -1.1M |
Add to Watchlist
Select watchlists to add or remove ZURA